SMART MEDICINE Trademark

Trademark Overview

On Monday, April 23, 2007, a trademark application was filed for SMART MEDICINE with the United States Patent and Trademark Office. The USPTO has given the SMART MEDICINE trademark a serial number of 77163274. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 12, 2021. This trademark is owned by OSIRIS THERAPEUTICS, INC.. The SMART MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells, for medical use; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory disease
smart medicine

General Information

Serial Number77163274
Word MarkSMART MEDICINE
Filing DateMonday, April 23, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 12, 2021
Registration Number3958016
Registration DateTuesday, May 10, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Goods and ServicesChemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells, for medical use; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 12, 2021
Primary Code005
First Use Anywhere DateMonday, April 23, 2007
First Use In Commerce DateThursday, October 21, 2010

Trademark Owner History

Party NameOSIRIS THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046
Party NameOSIRIS THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046
Party NameOSIRIS THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21046

Trademark Events

Event DateEvent Description
Friday, November 12, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, May 10, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 8, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 8, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 8, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 11, 2017TEAS SECTION 8 & 15 RECEIVED
Monday, July 18, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 18, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 10, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 7, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 7, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 10, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, April 5, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, April 2, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 1, 2011ASSIGNED TO LIE
Friday, April 1, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 25, 2011STATEMENT OF USE PROCESSING COMPLETE
Monday, February 21, 2011USE AMENDMENT FILED
Monday, February 21, 2011TEAS STATEMENT OF USE RECEIVED
Friday, February 18, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 17, 2011EXTENSION 2 GRANTED
Saturday, January 1, 2011EXTENSION 2 FILED
Thursday, February 17, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 1, 2011TEAS EXTENSION RECEIVED
Wednesday, August 4, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 2, 2010EXTENSION 1 GRANTED
Monday, August 2, 2010EXTENSION 1 FILED
Monday, August 2, 2010TEAS EXTENSION RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 29, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 29, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, September 29, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, May 8, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION E-MAILED
Friday, May 8, 2009NON-FINAL ACTION WRITTEN
Monday, April 20, 2009PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, April 13, 2009WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, April 2, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2009SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, September 8, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, August 12, 2008SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, August 12, 2008ASSIGNED TO LIE
Tuesday, February 12, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 12, 2008LETTER OF SUSPENSION E-MAILED
Tuesday, February 12, 2008SUSPENSION LETTER WRITTEN
Monday, January 14, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 14, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 11, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 11, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 15, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 15, 2007NON-FINAL ACTION E-MAILED
Wednesday, August 15, 2007NON-FINAL ACTION WRITTEN
Monday, August 6, 2007ASSIGNED TO EXAMINER
Thursday, April 26, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicine smart cells tissue which bone lineage mesenchymal regeneration stem pharmaceutical compositions